An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent Asthma

PHASE3

Phase

COMPLETED

Status

1526

Enrollment

INDUSTRY

Sponsor class

Conditions

DRUG: Fluticasone Furoate/Vilanterol 100/25 mcg via ELLIPTA inhaler
DRUG: Placebo inhalation powders via ELLIPTA inhaler
DRUG: Fluticasone Propionate/Salmeterol 250/50 mcg via ACCUHALER/DISKUS inhaler
DRUG: Placebo inhalation powder via ACCUHALER/DISKUS inhaler
DRUG: Fluticasone Propionate 250 mcg via ACCUHALER/DISKUS inhaler

GlaxoSmithKline